Current problems in cancer. Case reports最新文献

{"title":"A rare case of disseminated extra-nodal natural killer (NK) cell lymphoma","authors":"Sowbharnika Arivazhagan ,&nbsp;Guru Prasad Parthiban ,&nbsp;Sukanthini Subbiah","doi":"10.1016/j.cpccr.2024.100301","DOIUrl":"10.1016/j.cpccr.2024.100301","url":null,"abstract":"<div><p>Extranodal Natural Killer (NK)/T-cell lymphoma, nasal type, is rare and frequently found in Asia and South America. It is rarely found in the United States, mainly in the immigrant population. We present a 26-year-old male from Central America who was found to have disseminated NK/T-cell lymphoma. Through this article, we explain how we manage our patient and try to consolidate the treatment modalities for different stages of the disease.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"15 ","pages":"Article 100301"},"PeriodicalIF":0.2,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000243/pdfft?md5=6eb5903d14bb5eaf3853fd5ef41c986d&pid=1-s2.0-S2666621924000243-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141409017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A case report: A successfully treated erythrodermic mycosis fungoides with CHOP chemotherapy regiment and narrow band-UVB","authors":"Karina Survival Rofiq ,&nbsp;Merlyna Savitri ,&nbsp;Amira Rahmatika ,&nbsp;Linda Astari ,&nbsp;Ami Ashariati ,&nbsp;Siprianus Ugroseno Yudho Bintoro","doi":"10.1016/j.cpccr.2024.100300","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100300","url":null,"abstract":"<div><p>Mycosis fungoides (MF) is the most prevalent cutaneous T-cell lymphoma, with clinical symptoms comparable to erythroderma. An Indonesian female, 64-year-old, complained of itchy reddish skin and thick scales all over her body. She had a medical history of type 2 diabetes mellitus. Psoriasis vulgaris (erythroderma) was diagnosed and treated based on the signs and symptoms. The prognosis was not improved and a skin biopsy revealed mycosis fungoides (MF). Patient was treated with CHOP regiment, NB-UVB, and a combination of symptomatic therapies, which resulted in a favorable therapeutic response. Difficulties in diagnosis MF are caused by clinical signs and symptoms resembling dermatological disease. There is currently no cure for MF and the main purpose of treatment is illness management. Because the prognosis is poor at advance stage, an initial diagnosis and treatment are necessary to obtain a better prognosis.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"15 ","pages":"Article 100300"},"PeriodicalIF":0.0,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000231/pdfft?md5=786506b153ff4cafb85ca779c8c6265b&pid=1-s2.0-S2666621924000231-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141423116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Classic Hodgkin lymphoma transformation into composite lymphoma complicated with Guillain‒Barré syndrome after chemotherapy: A case report","authors":"Li He,&nbsp;Ying Bao","doi":"10.1016/j.cpccr.2024.100303","DOIUrl":"10.1016/j.cpccr.2024.100303","url":null,"abstract":"<div><p>Classic Hodgkin lymphoma rarely undergoes pathological transformation, and the transformation type is usually common non-Hodgkin lymphoma. This study describes a 71-year-old male diagnosed with stage III classic Hodgkin lymphoma positive for Epstein‒Barr virus. The disease was partially relieved soon after chemotherapy but quickly progressed with transformation into composite lymphoma with a mixture of T and B cells. Then he developed symptoms in his nervous system and was diagnosed with Guillain‒Barré syndrome. EBV remained positive throughout the course of the disease. Classic Hodgkin lymphoma may transform into composite lymphoma, and the composite lymphoma may be complicated with Guillain‒Barré syndrome after chemotherapy. We hypothesized that EBV infection may play a role in the progression of the disease.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"15 ","pages":"Article 100303"},"PeriodicalIF":0.2,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000267/pdfft?md5=d52393ce34d5ad93c828f7bd8f6bc877&pid=1-s2.0-S2666621924000267-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141277484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum regarding missing statements in previously published articles","authors":"","doi":"10.1016/j.cpccr.2023.100264","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100264","url":null,"abstract":"","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100264"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000480/pdfft?md5=5f66b2e80a1012a73ed52c0b85690ec1&pid=1-s2.0-S2666621923000480-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141323510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lamber-Eaton myasthenic syndrome associated with multiple myeloma: A case report","authors":"Sebastian S Casillas-Berumen ,&nbsp;Ahsan Salik ,&nbsp;Alex Yu ,&nbsp;Mageda Al Areqi ,&nbsp;Ayesha Ali ,&nbsp;Resham Mirza ,&nbsp;Shaan Chaudhri ,&nbsp;Gurpreet Lamba","doi":"10.1016/j.cpccr.2024.100299","DOIUrl":"10.1016/j.cpccr.2024.100299","url":null,"abstract":"<div><h3>Background</h3><p>Lambert-Eaton myasthenic syndrome (LEMS) is an uncommon illness of the neuromuscular junction. It typically manifests as a combination of proximal muscular weakness, autonomic dysfunction, and areflexia. It is typically associated with small cell lung cancer. However, this paraneoplastic syndrome has been discovered in other clinical entities, such as multiple myeloma, which is a rare and infrequent occurrence.</p></div><div><h3>Case presentation</h3><p>We report the case of 54-year-old female with history of tobacco usage, who presented with generalized weakness. The patient underwent multiple tests, including blood work up, electromyography, and imaging. The laboratory results yielded high protein levels and anemia, which prompted clinicians to pursue SPEP work up that yielded an elevated M spike, establishing MGUS diagnosis. Neurology evaluation was done in the setting of worsening symptoms. Antibody testing was positive for voltage-gated calcium channels, establishing diagnosis for Lambert-Eaton Myasthenic Syndrome. She underwent prednisone, pyridostigmine and amifampridine treatment noticing symptom improvement. Months later lab work showed unchanged M spike, and bone marrow biopsy showed 10 % IgA plasma cells, establishing Multiple Myeloma. She was started on daratumumab, decadron, lenalidomide and later on stem cell transplantation with success.</p></div><div><h3>Conclusions</h3><p>Coexistence of LEMS with multiple myeloma is a clinical entity with few published occurrences, providing diagnostic and therapy challenges due to the limited knowledge known about the potential link between the two.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100299"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266662192400022X/pdfft?md5=3ac70d4ec9a01085d5ea2e75f482554d&pid=1-s2.0-S266662192400022X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141276938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis, investigation, and treatment of occult breast cancer: A case report and systematic review of the literature","authors":"Nora Trabulsi ,&nbsp;Sarah Almaghrabi ,&nbsp;Basma Bamakhrama ,&nbsp;Zahir Fadel ,&nbsp;Alaa Shabkah ,&nbsp;Ali Farsi ,&nbsp;Basim Awan","doi":"10.1016/j.cpccr.2024.100296","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100296","url":null,"abstract":"<div><h3>Background</h3><p>Occult breast cancer (OBC) is an uncommon diagnosis that rarely causes skin metastasis. Our aim herein was to report a case of OBC with cutaneous metastasis and to systematically review the current evidence on the investigation, diagnosis, and treatment of such cases.</p></div><div><h3>Methods</h3><p>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A comprehensive search was conducted on MEDLINE, Embase, Cochrane Library, and Google Scholar. We included studies in English published from inception to August 2022 that included male or female patients who presented with OBC metastasis to the skin and that reported clinical outcomes of interest.</p></div><div><h3>Results</h3><p>We identified 854 articles, 13 of which were included in our review. The articles were case reports published between 2009 and 2022 and included 13 patients. The commonest site for skin lesions was the chest (<em>n</em> = 7), followed by the axilla (<em>n</em> = 5), of which 2 were bilateral. The skin lesions were nodular in 5 cases, macular in 2 cases, urticarial in 2 cases, papular in 1 case, and ulcerating in 2 cases. Skin metastasis was positive for estrogen receptor in 8 cases, progesterone receptor in 7 cases, cytokeratin 7 in 6 cases, and GATA binding protein 3 in 5 cases. Medical management was mostly by chemotherapy (<em>n</em> = 7) and hormonal therapy (<em>n</em> = 3). Surgical excision of the skin lesion was performed in 5 cases.</p></div><div><h3>Conclusion</h3><p>Cutaneous breast metastasis in the absence of the primary lesion is a rare phenomenon. Most cases reviewed were managed with multimodal approach including surgical and medical management. This review provides reference for physicians coming across similar cases.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100296"},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266662192400019X/pdfft?md5=993450f559666c545da066ded6832304&pid=1-s2.0-S266662192400019X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141083352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alpelisib (phosphatidylinositol 3-kinase inhibitor) induced uncontrolled hyperglycemia and colitis","authors":"Sanchit Duhan ,&nbsp;Nadeem Tabbara ,&nbsp;Bijeta Keisham ,&nbsp;Nymisha Boddeti ,&nbsp;Daniel A. Laheru","doi":"10.1016/j.cpccr.2024.100294","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100294","url":null,"abstract":"<div><p>Alpelisib is currently the only Phosphatidylinositol 3-kinase (PI3K) inhibitor approved for treating endocrine therapy-resistant metastatic breast cancer with a Phosphatidylinositol-4,5-bisphosphonate 3-kinase catalytic subunit alpha (PIK3CA)-mutation. Significant side effects of treatment include hepatotoxicity, hyperglycemia, diarrhea, nausea, stomatitis, fatigue, anorexia, and rash. We discuss the case of a 71-year-old woman with PI3K-mutated metastatic breast cancer and diabetes who presented with abdominal pain, nausea, and anorexia. She was started on alpelisib 250 mg daily four days before the hospital presentation. Notable labs at presentation included a glucose of 537 mg/dL and intrinsic renal acute kidney injury (AKI) with a creatinine of 1.6 mg/dL (baseline 1.2–1.3 mg/dL). A Computed Tomography (CT) scan was suggestive of typhlitis/colitis. After excluding other causes of hyperglycemia, she was diagnosed with alpelisib-induced hyperglycemia. Hyperglycemia with alpelisib is often severe and should prompt immediate consultation with endocrinology. Sodium-glucose co-transporter (SGLT) -2 inhibitors have been the most studied. However, concurrent kidney injuries may limit their real-world application. Alpelisib-associated complications subjected our patient to additional imaging, antibiotics, and prolonged hospital stay (6 days). The overall survival is not significantly increased with alpelisib as per the currently available data. More prospective trials will help assess and balance this drug's safety/efficacy profile to achieve better outcomes.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100294"},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000176/pdfft?md5=f6aba6ed2552a9ca1b2a17d2044f679d&pid=1-s2.0-S2666621924000176-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advanced non-small cell lung cancer patient with a complete response and allergic immune-related adverse events by combined immunotherapy, including anti-CTLA-4 and anti-PD-1 antibodies: A case report","authors":"Chiho Nakashima ,&nbsp;Yuki Kuwahara ,&nbsp;Syo Kitamura ,&nbsp;Keita Kai ,&nbsp;Masafumi Hiratsuka ,&nbsp;Kokoro Kajiwara ,&nbsp;Natsuko Komiya ,&nbsp;Shinsuke Ogusu ,&nbsp;Shinya Kimura ,&nbsp;Naoko Sueoka-Aragane","doi":"10.1016/j.cpccr.2024.100298","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100298","url":null,"abstract":"<div><p>Immune checkpoint inhibitors (ICIs) are indispensable agents that may improve the long-term prognosis of non-small cell lung cancer. However, clinicians should always be aware that its immune-modulating mechanism of action may lead to unexpected immune-related adverse events (irAE). We report here a case of a 72-year-old man with adenocarcinoma of the lung who achieved a complete response to nivolumab plus ipilimumab plus chemotherapy but also suffered from a variety of immune-related adverse events. In this patient, Th1 immunity, which is involved in antitumor immunity, and Th2 immunity were activated, resulting in allergy-related reactions, including increased airway hyperresponsiveness and a marked increase in serum IgE levels. After starting corticosteroids, the allergic symptoms were well controlled. Remarkably, despite discontinuing ICI treatment, the patient has maintained a complete response for 27 months. Fortunately, we obtained lung and lymph node tissues from this patient after ICI administration and histologically examined the Th1 and Th2 immune status.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100298"},"PeriodicalIF":0.0,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000218/pdfft?md5=5986a42e2b6da6b36d5f1db3b63fca88&pid=1-s2.0-S2666621924000218-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141072790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acro metastasis: A rare presentation in a common cancer","authors":"Ali Ghanei-Shahmirzadi ,&nbsp;Nasrin Namdari ,&nbsp;Maral Mokhtari ,&nbsp;Pooya Iranpour","doi":"10.1016/j.cpccr.2024.100292","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100292","url":null,"abstract":"<div><h3>Background</h3><p>Case presentation: In this study, we presented an Iranian female with triple-negative breast cancer that developed acro-metastasis to the hand</p></div><div><h3>Conclusions</h3><p>However, bone metastasis is the most common kind of neoplasm extension that we can witness in the breast cancer, acro-metastasis to the hand is an extremely rare kind of bone metastasis that we can expect.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100292"},"PeriodicalIF":0.0,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000152/pdfft?md5=2627aafdb6a031d098aba25351b77491&pid=1-s2.0-S2666621924000152-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inflammation of actinic keratoses after the use of docetaxel plus cyclophosphamide","authors":"Ashley Wittmer ,&nbsp;Lindsey Finklea ,&nbsp;Jonathan Joseph","doi":"10.1016/j.cpccr.2024.100293","DOIUrl":"10.1016/j.cpccr.2024.100293","url":null,"abstract":"<div><p>Actinic keratoses are common pre-malignant lesions of the skin that have been documented to become inflamed after the use of chemotherapy. Several agents, such as 5-fluorouracil, capecitabine, pentostatin, dactinomycin, vincristine, dacarbazine, cytarabine, 6-thioguanine, sorafenib, paclitaxel, and docetaxel have been documented to cause this reaction. This case report aims to describe the inflammation of actinic keratoses in response to docetaxel plus cyclophosphamide. A 64-year-old woman undergoing chemotherapy for breast cancer presented to the clinic with multiple scaly, erythematous papules covering her shoulders, arms, chest, and back. This occurred 15 days after treatment with IV docetaxel plus cyclophosphamide. The results of the shave biopsies done at the visit were consistent with inflammation. She was treated with topical triamcinolone ointment and the inflammation greatly improved within one month. The inflammation was completely resolved two months after completing therapy with docetaxel plus cyclophosphamide. Documentation of cutaneous adverse events help provide awareness of this reaction and thereby prevent cessation of necessary cancer treatments. Further research is needed to determine which patients undergoing chemotherapy may be susceptible to inflammation of actinic keratoses.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"14 ","pages":"Article 100293"},"PeriodicalIF":0.0,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000164/pdfft?md5=b2323e149187f056d021ab472e000e66&pid=1-s2.0-S2666621924000164-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141040979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}